|LAUNCH PLANNING||CORE MARKET ASSESSMENT|
|PRIORITIZATION OF MARKET ENTRY ACTIVITIES||ANALYSIS OF PRESCRIBERS AND HCPS|
A full cycle of analytical, expert and research support services for Pharma and MedTech companies during their way to enter the region:
We adapt each launch-plan exclusively for each brand, market niche and global / regional brand strategy and the set of company goals.
We accompany generic and innovative companies in analyzing of their brands' sales effectiveness in the region:
Virtually every project which we delivered included a regulatory environment analysis section per each target product or market. We'd always fulfilled those requests, both independently and by involving our partners - Life Sciences law firms, independent lawyers and specialists in each particular area.
Comprehensive assessment of the regulatory environment in the target market or therapeutic group:
We analyse regulatory environment in all countries of the CIS and Central Asia.
We analyze the regulatory environment for all types of pharma products and medical equipment:
|TARGET MARKET ASSESSMENT
Collection, processing and analysis of a market data, assessment of market potential and saturation, regular reporting on a core market.
|ANALYSIS OF COMPETITION
Identification and study of existing competitors in a core market, price segments, positioning strategy of each competitor and competitive products.
|QUALITATIVE RESEARCH OF STAKEHOLDERS
identification, research and uncover their impact level on the market, studies of perception and attitude, influence level on the product or market.
1-3 years sales forecast modelling, identification of market risks and factors influencing future sales, assessment of possible sales volumes in the CIS and Central Asia
Pharma & MedTech Market Access Strategy, Marketing Analysis, market-entry issues, stakeholders mapping etc. - Eugene Brovko tel.: +380 (44) 232-11-42 or via e-mail: EBrovko@upharma-c.com to clarify all questions regarding Market Access services.
Leave your message